Reuters exclusively reports U.S. could authorize Pfizer COVID-19 shot for kids age 5-11 in October - Reuters News Agency
Health

Reuters exclusively reports U.S. could authorize Pfizer COVID-19 shot for kids age 5-11 in October

Reuters’ Marisa Taylor and Dan Levine exclusively reported that top U.S. health officials believe that Pfizer Inc’s COVID-19 vaccine could be authorized for children aged 5-11 years old by the end of October. The decision on whether to authorize a vaccine for younger children is eagerly anticipated by millions of Americans, particularly parents whose children started school in recent weeks amid a wave of infections driven by the Delta variant.

Article Tags
Topics of Interest: Health
Type: Reuters Best
Sectors: Pharmaceuticals & Healthcare
Regions: North America
Win Types: Exclusivity
Story Types: Exclusive / Scoop
Media Types: Text
Customer Impact: Important Regional Story
Sign up for email updates

Subscribe
Sign up for email updates